Skip to main content
Top
Published in: Heart and Vessels 11/2017

01-11-2017 | Original Article

Nutritional screening based on the controlling nutritional status (CONUT) score at the time of admission is useful for long-term prognostic prediction in patients with heart failure requiring hospitalization

Authors: Isao Nishi, Yoshihiro Seo, Yoshie Hamada-Harimura, Kimi Sato, Seika Sai, Masayoshi Yamamoto, Tomoko Ishizu, Akinori Sugano, Kenichi Obara, Longmei Wu, Shoji Suzuki, Akira Koike, Kazutaka Aonuma, Ibaraki Cardiovascular Assessment Study-Heart Failure Investigators

Published in: Heart and Vessels | Issue 11/2017

Login to get access

Abstract

The objective of the study was to clarify whether controlling nutritional status (CONUT) is useful for predicting the long-term prognosis of patients hospitalized with heart failure (HF). A total of 482 (57.5%) HF patients from the Ibaraki Cardiovascular Assessment Study-HF (N = 838) were enrolled (298 men, 71.7 ± 13.6 years). At admission, blood samples were collected and nutritional status assessed using CONUT. CONUT scores were defined as follows: 0–1, normal; 2–4, light; 5–8, moderate; and 9–12, severe undernutrition. Accordingly, 352 (73%) patients had light-to-severe nutritional disturbances. In the follow-up period [median 541.5 (range 354–786) days], 109 deaths were observed. A Kaplan–Meier analysis revealed that all-cause deaths occurred more frequently in HF patients with nutritional disturbances [n = 93 (26.4%)] than in those with normal nutrition [n = 16 (12.3%); log-rank p < 0.001]. The Cox proportional hazard analyses revealed that a per point increase in the CONUT score was associated with an increased risk of all-cause death (hazard ratio 1.142; 95% confidence interval, 1.044–1.249) after controlling simultaneously for age, sex, previous history of HF hospitalization, log brain natriuretic peptide, and use of therapeutic agents at admission (tolvaptan and aldosterone antagonists). This study suggests that nutritional screening using CONUT scores is helpful in predicting the long-term prognosis of patients hospitalized with HF in a multicenter registry setting.
Literature
1.
go back to reference Shiba N (2012) Chronic heart failure: progress in diagnosis and treatment. Topics: I. Progress in epidemiology and fundamental research; 1. Epidemiology of chronic heart failure. Nihon Naika Gakkai Zasshi 101:307–313 in Japanese CrossRefPubMed Shiba N (2012) Chronic heart failure: progress in diagnosis and treatment. Topics: I. Progress in epidemiology and fundamental research; 1. Epidemiology of chronic heart failure. Nihon Naika Gakkai Zasshi 101:307–313 in Japanese CrossRefPubMed
2.
go back to reference Bonilla-Palomas JL, Gámez-López AL, Anguita-Sánchez MP, Castillo-Domínguez JC, García-Fuertes D, Crespin-Crespin M, López-Granados A, Suárez de Lezo J (2011) Impact of malnutrition on long-term mortality in hospitalized patients with heart failure. Rev Esp Cardiol (Engl Ed) 64:752–758CrossRef Bonilla-Palomas JL, Gámez-López AL, Anguita-Sánchez MP, Castillo-Domínguez JC, García-Fuertes D, Crespin-Crespin M, López-Granados A, Suárez de Lezo J (2011) Impact of malnutrition on long-term mortality in hospitalized patients with heart failure. Rev Esp Cardiol (Engl Ed) 64:752–758CrossRef
3.
go back to reference Ignacio de Ulíbarri J, González-Madroño A, de Villar NG, González P, González B, Mancha A, Rodríguez F, Fernández G (2005) CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp 20:38–45PubMed Ignacio de Ulíbarri J, González-Madroño A, de Villar NG, González P, González B, Mancha A, Rodríguez F, Fernández G (2005) CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp 20:38–45PubMed
4.
go back to reference Suzuki N, Kida K, Akashi Y, Musha H, Miyake F (2013) Usefulness of nutritional assessment using CONUT at admission and short-term prognosis in patients with acute heart failure. Jomyaku Keicho Eiyo 28:1083–1090 (in Japanese) Suzuki N, Kida K, Akashi Y, Musha H, Miyake F (2013) Usefulness of nutritional assessment using CONUT at admission and short-term prognosis in patients with acute heart failure. Jomyaku Keicho Eiyo 28:1083–1090 (in Japanese)
5.
go back to reference Agra Bermejo RM, González Ferreiro R, Varela Román A, Gómez Otero I, Kreidieh O, Conde Sabarís P, Rodríguez-Mañero M, Moure González M, Seoane Blanco A, Virgós Lamela A, García Castelo A, González Juanatey JR (2017) Nutritional status is related to heart failure severity and hospital readmissions in acute heart failure. Int J Cardiol 230:108–114CrossRefPubMed Agra Bermejo RM, González Ferreiro R, Varela Román A, Gómez Otero I, Kreidieh O, Conde Sabarís P, Rodríguez-Mañero M, Moure González M, Seoane Blanco A, Virgós Lamela A, García Castelo A, González Juanatey JR (2017) Nutritional status is related to heart failure severity and hospital readmissions in acute heart failure. Int J Cardiol 230:108–114CrossRefPubMed
6.
go back to reference Iwakami N, Nagai T, Furukawa TA, Sugano Y, Honda S, Okada A, Asaumi Y, Aiba T, Noguchi T, Kusano K, Ogawa H, Yasuda S, Anzai T, NaDEF investigators (2017) Prognostic value of malnutrition assessed by Controlling Nutritional Status score for long-term mortality in patients with acute heart failure. Int J Cardiol 230:529–536CrossRefPubMed Iwakami N, Nagai T, Furukawa TA, Sugano Y, Honda S, Okada A, Asaumi Y, Aiba T, Noguchi T, Kusano K, Ogawa H, Yasuda S, Anzai T, NaDEF investigators (2017) Prognostic value of malnutrition assessed by Controlling Nutritional Status score for long-term mortality in patients with acute heart failure. Int J Cardiol 230:529–536CrossRefPubMed
7.
go back to reference Narumi T, Arimoto T, Funayama A, Kadowaki S, Otaki Y, Nishiyama S, Takahashi H, Shishido T, Miyashita T, Miyamoto T, Watanabe T, Kubota I (2013) Prognostic importance of objective nutritional indexes in patients with chronic heart failure. J Cardiol 62:307–313CrossRefPubMed Narumi T, Arimoto T, Funayama A, Kadowaki S, Otaki Y, Nishiyama S, Takahashi H, Shishido T, Miyashita T, Miyamoto T, Watanabe T, Kubota I (2013) Prognostic importance of objective nutritional indexes in patients with chronic heart failure. J Cardiol 62:307–313CrossRefPubMed
8.
go back to reference Nochioka K, Sakata Y, Takahashi J, Miyata S, Miura M, Takada T, Fukumoto Y, Shiba N, Shimokawa H, CHART-2 Investigators (2013) Prognostic impact of nutritional status in asymptomatic patients with cardiac diseases: a report from the CHART-2 Study. Circ J 77:2318–2326CrossRefPubMed Nochioka K, Sakata Y, Takahashi J, Miyata S, Miura M, Takada T, Fukumoto Y, Shiba N, Shimokawa H, CHART-2 Investigators (2013) Prognostic impact of nutritional status in asymptomatic patients with cardiac diseases: a report from the CHART-2 Study. Circ J 77:2318–2326CrossRefPubMed
9.
go back to reference Nishi I, Seo Y, Hamada-Harimura Y, Sato K, Sai S, Yamamoto M, Ishizu T, Sugano A, Obara K, Wu L, Suzuki S, Koike A, Aonuma K (2017) Utility of nutritional screening in predicting short-term prognosis of heart failure patients. Int Heart J 59. doi:10.1536/ihj.17-073 Nishi I, Seo Y, Hamada-Harimura Y, Sato K, Sai S, Yamamoto M, Ishizu T, Sugano A, Obara K, Wu L, Suzuki S, Koike A, Aonuma K (2017) Utility of nutritional screening in predicting short-term prognosis of heart failure patients. Int Heart J 59. doi:10.​1536/​ihj.​17-073
10.
go back to reference Bellomo R, Warrillow SJ, Reade MC (2009) Why we should be wary of single-center trials. Crit Care Med 37:3114–3119CrossRefPubMed Bellomo R, Warrillow SJ, Reade MC (2009) Why we should be wary of single-center trials. Crit Care Med 37:3114–3119CrossRefPubMed
11.
go back to reference Dechartres A, Boutron I, Trinquart L, Charles P, Ravaud P (2011) Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study. Ann Intern Med 155:39–51CrossRefPubMed Dechartres A, Boutron I, Trinquart L, Charles P, Ravaud P (2011) Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study. Ann Intern Med 155:39–51CrossRefPubMed
12.
go back to reference Unverzagt S, Prondzinsky R, Peinemann F (2013) Single-center trials tend to provide larger treatment effects than multicenter trials: a systematic review. J Clin Epidemiol 66:1271–1280CrossRefPubMed Unverzagt S, Prondzinsky R, Peinemann F (2013) Single-center trials tend to provide larger treatment effects than multicenter trials: a systematic review. J Clin Epidemiol 66:1271–1280CrossRefPubMed
13.
go back to reference Feldman AM, Bristow MR, Parmley WW, Carson PE, Pepine CJ, Gilbert EM, Strobeck JE, Hendrix GH, Powers ER, Bain RP, White BG, for the Vesnarinone Study Group (1993) Effects of vesnarinone on morbidity and mortality in patients with heart failure. N Engl J Med 329:149–155CrossRefPubMed Feldman AM, Bristow MR, Parmley WW, Carson PE, Pepine CJ, Gilbert EM, Strobeck JE, Hendrix GH, Powers ER, Bain RP, White BG, for the Vesnarinone Study Group (1993) Effects of vesnarinone on morbidity and mortality in patients with heart failure. N Engl J Med 329:149–155CrossRefPubMed
14.
go back to reference Cohn JN, Goldstein SO, Greenberg BH, Lorell BH, Bourge RC, Jaski BE, Gottlieb SO, McGrew F 3rd, DeMets DL, White BG (1998) A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators. N Engl J Med 339:1810–1816CrossRefPubMed Cohn JN, Goldstein SO, Greenberg BH, Lorell BH, Bourge RC, Jaski BE, Gottlieb SO, McGrew F 3rd, DeMets DL, White BG (1998) A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators. N Engl J Med 339:1810–1816CrossRefPubMed
15.
go back to reference Packer M, O’Connor CM, Ghali JK, Pressler ML, Carson PE, Belkin RN, Miller AB, Neuberg GW, Frid D, Wertheimer JH, Cropp AB, DeMets DL (1996) Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective randomized amlodipine survival evaluation study group. N Engl J Med 335:1107–1114CrossRefPubMed Packer M, O’Connor CM, Ghali JK, Pressler ML, Carson PE, Belkin RN, Miller AB, Neuberg GW, Frid D, Wertheimer JH, Cropp AB, DeMets DL (1996) Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective randomized amlodipine survival evaluation study group. N Engl J Med 335:1107–1114CrossRefPubMed
16.
go back to reference Packer M, Carson P, Elkayam U, Konstam MA, Moe G, O’Connor C, Rouleau JL, Schocken D, Anderson SA, DeMets DL, PRAISE-2 Study Group (2013) Effect of amlodipine on the survival of patients with severe chronic heart failure due to a nonischemic cardiomyopathy: results of the PRAISE-2 study (Prospective Randomized Amlodipine Survival Evaluation 2). JACC Heart Fail 1:308–314CrossRefPubMed Packer M, Carson P, Elkayam U, Konstam MA, Moe G, O’Connor C, Rouleau JL, Schocken D, Anderson SA, DeMets DL, PRAISE-2 Study Group (2013) Effect of amlodipine on the survival of patients with severe chronic heart failure due to a nonischemic cardiomyopathy: results of the PRAISE-2 study (Prospective Randomized Amlodipine Survival Evaluation 2). JACC Heart Fail 1:308–314CrossRefPubMed
17.
go back to reference Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, Deedwania PC, Ney DE, Snavely DB, Chang PI (1997) Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 349(9054):747–752CrossRefPubMed Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, Deedwania PC, Ney DE, Snavely DB, Chang PI (1997) Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 349(9054):747–752CrossRefPubMed
18.
go back to reference Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, Konstam MA, Riegger G, Klinger GH, Neaton J, Sharma D, Thiyagarajan B (2000) Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II. Lancet 355(9215):1582–1587CrossRefPubMed Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, Konstam MA, Riegger G, Klinger GH, Neaton J, Sharma D, Thiyagarajan B (2000) Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II. Lancet 355(9215):1582–1587CrossRefPubMed
19.
go back to reference McKee PA, Castelli WP, McNamara PM, Kannel WB (1971) The natural history of congestive heart failure: the Framingham study. N Engl J Med 285:1441–1446CrossRefPubMed McKee PA, Castelli WP, McNamara PM, Kannel WB (1971) The natural history of congestive heart failure: the Framingham study. N Engl J Med 285:1441–1446CrossRefPubMed
20.
go back to reference Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, Collaborators developing the Japanese equation for estimated GFR (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982–992CrossRefPubMed Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, Collaborators developing the Japanese equation for estimated GFR (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982–992CrossRefPubMed
21.
go back to reference La Rovere MT, Maestri R, Olmetti F, Paganini V, Riccardi G, Riccardi R, Pinna GD, Traversi E (2017) Additional predictive value of nutritional status in the prognostic assessment of heart failure patients. Nutr Metab Cardiovasc Dis 27:274–280CrossRefPubMed La Rovere MT, Maestri R, Olmetti F, Paganini V, Riccardi G, Riccardi R, Pinna GD, Traversi E (2017) Additional predictive value of nutritional status in the prognostic assessment of heart failure patients. Nutr Metab Cardiovasc Dis 27:274–280CrossRefPubMed
22.
go back to reference Nakaya Y (2015) Nutritional assessment in patients with heart failure. Jpn J Clin Nutr 127:296–302 (in Japanese) Nakaya Y (2015) Nutritional assessment in patients with heart failure. Jpn J Clin Nutr 127:296–302 (in Japanese)
23.
go back to reference Desai AS, Claggett B, Pfeffer MA, Bello N, Finn PV, Granger CB, McMurray JJ, Pocock S, Swedberg K, Yusuf S, Solomon SD (2014) Influence of hospitalization for cardiovascular versus noncardiovascular reasons on subsequent mortality in patients with chronic heart failure across the spectrum of ejection fraction. Circ Heart Fail 7:895–902CrossRefPubMed Desai AS, Claggett B, Pfeffer MA, Bello N, Finn PV, Granger CB, McMurray JJ, Pocock S, Swedberg K, Yusuf S, Solomon SD (2014) Influence of hospitalization for cardiovascular versus noncardiovascular reasons on subsequent mortality in patients with chronic heart failure across the spectrum of ejection fraction. Circ Heart Fail 7:895–902CrossRefPubMed
24.
go back to reference Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Authors/Task Force Members (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129–2200CrossRefPubMed Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Authors/Task Force Members (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129–2200CrossRefPubMed
25.
go back to reference Rahman A, Jafry S, Jeejeebhoy K, Nagpal AD, Pisani B, Agarwala R (2016) Malnutrition and cachexia in heart failure. JPEN J Parenter Enteral Nutr 40:475–486CrossRefPubMed Rahman A, Jafry S, Jeejeebhoy K, Nagpal AD, Pisani B, Agarwala R (2016) Malnutrition and cachexia in heart failure. JPEN J Parenter Enteral Nutr 40:475–486CrossRefPubMed
26.
go back to reference Deutz NE, Matheson EM, Matarese LE, Luo M, Baggs GE, Nelson JL, Hegazi RA, Tappenden KA, Ziegler TR, NOURISH Study Group (2016) Readmission and mortality in malnourished, older, hospitalized adults treated with a specialized oral nutritional supplement: a randomized clinical trial. Clin Nutr 35:18–26CrossRefPubMed Deutz NE, Matheson EM, Matarese LE, Luo M, Baggs GE, Nelson JL, Hegazi RA, Tappenden KA, Ziegler TR, NOURISH Study Group (2016) Readmission and mortality in malnourished, older, hospitalized adults treated with a specialized oral nutritional supplement: a randomized clinical trial. Clin Nutr 35:18–26CrossRefPubMed
27.
go back to reference Gámez-López AL, Bonilla-Palomas JL, Anguita-Sánchez M, Moreno-Conde M, López-Ibáñez C, Alhambra-Expósito R, Castillo-Domínguez JC, Villar-Ráez A, Suárez de Lezo J (2014) Rationale and design of PICNIC study: nutritional intervention program in hospitalized patients with heart failure who are malnourished. Rev Esp Cardiol (Engl Ed) 67:277–282CrossRef Gámez-López AL, Bonilla-Palomas JL, Anguita-Sánchez M, Moreno-Conde M, López-Ibáñez C, Alhambra-Expósito R, Castillo-Domínguez JC, Villar-Ráez A, Suárez de Lezo J (2014) Rationale and design of PICNIC study: nutritional intervention program in hospitalized patients with heart failure who are malnourished. Rev Esp Cardiol (Engl Ed) 67:277–282CrossRef
28.
go back to reference Allard ML, Jeejeebhoy KN, Sole MJ (2006) The management of conditioned nutritional requirements in heart failure. Heart Fail Rev 11:75–82CrossRefPubMed Allard ML, Jeejeebhoy KN, Sole MJ (2006) The management of conditioned nutritional requirements in heart failure. Heart Fail Rev 11:75–82CrossRefPubMed
29.
go back to reference Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C, Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators (2007) Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 297:1319–1331CrossRefPubMed Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C, Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators (2007) Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 297:1319–1331CrossRefPubMed
30.
go back to reference Hanatani A, Shibata A, Kitada R, Iwata S, Matsumura Y, Doi A, Sugioka K, Takagi M, Yoshiyama M (2017) Administration of tolvaptan with reduction of loop diuretics ameliorates congestion with improving renal dysfunction in patients with congestive heart failure and renal dysfunction. Heart Vessels 32:287–294CrossRefPubMed Hanatani A, Shibata A, Kitada R, Iwata S, Matsumura Y, Doi A, Sugioka K, Takagi M, Yoshiyama M (2017) Administration of tolvaptan with reduction of loop diuretics ameliorates congestion with improving renal dysfunction in patients with congestive heart failure and renal dysfunction. Heart Vessels 32:287–294CrossRefPubMed
31.
go back to reference Matsukawa R, Kubota T, Okabe M, Yamamoto Y (2016) Early use of V2 receptor antagonists is associated with a shorter hospital stay and reduction in in-hospital death in patients with decompensated heart failure. Heart Vessels 31:1650–1658CrossRefPubMed Matsukawa R, Kubota T, Okabe M, Yamamoto Y (2016) Early use of V2 receptor antagonists is associated with a shorter hospital stay and reduction in in-hospital death in patients with decompensated heart failure. Heart Vessels 31:1650–1658CrossRefPubMed
32.
go back to reference Uemura Y, Shibata R, Takemoto K, Uchikawa T, Koyasu M, Ishikawa S, Mitsuda T, Miura A, Imai R, Iwamiya S, Ozaki Y, Kato T, Miura T, Watarai M, Murohara T (2016) Clinical benefit of tolvaptan in patients with acute decompensated heart failure and chronic kidney disease. Heart Vessels 31:1643–1649CrossRefPubMed Uemura Y, Shibata R, Takemoto K, Uchikawa T, Koyasu M, Ishikawa S, Mitsuda T, Miura A, Imai R, Iwamiya S, Ozaki Y, Kato T, Miura T, Watarai M, Murohara T (2016) Clinical benefit of tolvaptan in patients with acute decompensated heart failure and chronic kidney disease. Heart Vessels 31:1643–1649CrossRefPubMed
Metadata
Title
Nutritional screening based on the controlling nutritional status (CONUT) score at the time of admission is useful for long-term prognostic prediction in patients with heart failure requiring hospitalization
Authors
Isao Nishi
Yoshihiro Seo
Yoshie Hamada-Harimura
Kimi Sato
Seika Sai
Masayoshi Yamamoto
Tomoko Ishizu
Akinori Sugano
Kenichi Obara
Longmei Wu
Shoji Suzuki
Akira Koike
Kazutaka Aonuma
Ibaraki Cardiovascular Assessment Study-Heart Failure Investigators
Publication date
01-11-2017
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 11/2017
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-017-1001-8

Other articles of this Issue 11/2017

Heart and Vessels 11/2017 Go to the issue